Global Allergy Diagnostics Market

Allergy Diagnostics Market Size, Share, Growth Analysis, By Product(Consumables, Instruments (Immunoassay Analyzers, ELISA Analyzers, Luminometers), By Allergens(Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), By Test Type(Vivo Tests (Skin Prick Tests, Patch Tests, Other In Vivo Tests), In Vitro Tests), By End User(Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users), By Region - Industry Forecast 2024-2031


Report ID: SQSG35I2040 | Region: Global | Published Date: September, 2024
Pages: 165 | Tables: 123 | Figures: 73

Allergy Diagnostics Market Insights

Allergy Diagnostics Market size was valued at around USD 4.3 billion in 2022 and is expected to rise from USD 4.8 billion in 2023 to reach a value of USD 11.1 billion by 2031, at a CAGR of 11% over the forecast period (2024–2031).

The allergy diagnostics market has been witnessing notable growth in the recent past, impacted by the growing prevalence of allergies, improvements in diagnostic technologies, and rising awareness of allergy testing. There has been a notable rise in commonly seen allergic conditions like hay fever, asthma, and multiple food allergies along with numerous environmental factors and lifestyle changes. All these majorly contribute to the expansion of the allergy diagnostics market. Moreover, modernizations in diagnostic technologies and tools, including skin prick tests, vitro testing, and molecular diagnostics improve efficiency and accuracy.

Nevertheless, the global allergy diagnostics market is restrained by different regulatory hurdles and significantly priced diagnostic technologies. Stringent regulations associated with diagnostic tests may notably slow down the market entry of novel products and technologies, which may hamper market growth. Also, the high price of advanced diagnostic technologies may be a challenge for a few patients as well as for most healthcare systems. In addition, lack of standardization may hinder market growth. Due to absence of standardized testing procedure, the test may offer variable results, thus reducing overall reliability of allergy diagnostics. Yet, the market is projected to witness considerable growth owing to opportunities like emergence of innovative diagnostic procedures, integration of ML and AI, and heavy investments in healthcare infrastructure and growing awareness of allergies and benefits of diagnostics.

US Allergy Diagnostics Market  is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Allergy Diagnostics Market size was valued at around USD 4.3 billion in 2022 and is expected to rise from USD 4.8 billion in 2023 to reach a value of USD 11.1 billion by 2031, at a CAGR of 11% over the forecast period (2024–2031).

The competitive landscape of the global allergy diagnostics market is differentiated by the amalgamation of emerging companies and well-established players with ongoing strategic partnerships and innovations, reshaping the market. Prominent players like Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, and Roche are focusing on in vitro diagnostics, comprehensive allergen testing competencies, and improved diagnostic tests and platforms for the detection of allergies. Furthermore, small enterprises and progressing companies are emphasizing niche products or modernized testing techniques like digital health solutions and molecular diagnostics. To boost rankings, established companies are heavily investing in R&D, engaging in collaborations, and increasing their geographic presence. 'Danaher Corporation ', 'Thermo Fisher Scientific Inc. ', 'Canon, Inc. (Minaris Medical America, Inc.) ', 'Siemens Healthineers AG ', 'Eurofins Scientific ', 'Revvity, Inc. (Euroimmun Medizinische Labor diagnostika AG) ', 'BioMérieux SA ', 'Stallergenes Greer Ltd. ', 'Romer Labs Division Holding GmbH ', 'HollisterStier Allergy ', 'Omega Diagnostics Group PLC ', 'HOB Biotech Group Corp., Ltd. ', 'Hycor Biomedical ', 'Lincoln Diagnostics, Inc. ', 'R-Biopharm AG ', 'Astra Biotech GmbH ', 'Erba Group ', 'AESKU.GROUP GmbH ', 'ACON Laboratories, Inc. ', 'Alcit India Pvt. Ltd. ', 'Biopanda Reagents Ltd. ', 'Bioside S.R.L. ', 'Creative Diagnostic Medicare Pvt. Ltd. ', 'DST Diagnostische Systeme & Technologien GmbH ', 'Dr. Fooke Laboratorien GmbH'

The inclination towards personalized medicine is notably impacting allergy diagnostics. There is an increase demand for allergy tests that offer deep vision into personal sensitivities, enabling for more customized and personalized treatment decisions. Current research in detecting certain biomarkers associated with allergies improves the ability to create tailored treatment tactics, thus impacting the market growth. 

Mounting Use of Molecular Diagnostics: Molecular diagnostic techniques like allergen component testing and next-generation sequencing are gaining prominence. These techniques enable more accurate detection of certain allergens at molecular stage. This trend improves precision of diagnostics, allowing better customized treatment plans depending on patient sensitivities. This ultimately results in better patient results. The commonly used molecular diagnostic methods include ELISA, PCR, and NHS. 

Region-wise, North America dominated the market in the previous years and is expected to lead over the forecast period owing to rising incidences of allergies, improved healthcare infrastructure, and education and strong awareness. The region reports a higher number of allergic conditions as compared to other regions. These comprise various food allergies, allergic rhinitis, asthma, and more, which demand on reliable diagnostic facilities a large scale. Also, North America holds a well-established healthcare infrastructure with easy access to superior diagnostic techniques and an expert workforce. This streamlines accuracy and time testing. Also, the public awareness regarding allergies is higher than other regions, resulting in proactive medical industry seeking high demand for testing. The key players profiled in the region include Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, Roche Diagnostics, ALK-Abelló, and more.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Allergy Diagnostics Market

Report ID: SQSG35I2040

$5,300
BUY NOW GET FREE SAMPLE